文献速递慢性肾脏病遗传性与小管间质肾病

抑制粘着斑激酶可改善多囊肾小鼠模型的囊肿发展

Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model.
PubMed 文献 · J Am Soc Nephrol · 2021-01-01

本研究在体外三维囊肿模型、离体胚胎肾培养及两种Pkd1敲除小鼠模型中探讨粘着斑激酶(FAK)在常染色体显性多囊肾病(ADPKD)中的作用。结果显示FAK活性在ADPKD细胞和小鼠中升高,抑制FAK可减少细胞增殖、延缓囊肿发展并减轻肾功能下降,机制涉及cAMP-PKA-FAK-Src-ERK/mTOR通路。

要点

  • FAK活性在ADPKD细胞和两种Pkd1敲除小鼠模型中显著升高。
  • FAK抑制剂可减少囊肿衬里细胞增殖并延缓小鼠囊肿发展。
  • FAK通过cAMP-PKA调控的Src-ERK/mTOR通路促进囊肿形成。

核心结论

  • FAK在肾囊肿发展中起关键作用,是ADPKD的潜在治疗靶点。
  • FAK参与cAMP-PKA调控的增殖通路。

研究设计与样本

  • 研究采用FSK诱导的三维MDCK囊肿模型和8-Br-cAMP刺激的离体胚胎肾培养。
  • 使用人肾囊肿衬里细胞(OX-161)和正常肾小管上皮细胞进行增殖研究。
  • 使用两种转基因ADPKD小鼠模型:肾脏特异性Pkd1敲除和集合管特异性Pkd1敲除。

主要发现

  • FAK活性在OX-161细胞和两种ADPKD小鼠模型中显著升高。
  • 抑制FAK活性减少OX-161细胞增殖,并在离体和三维囊肿模型中阻止囊肿生长。
  • 在组织特异性Pkd1敲除小鼠中,FAK抑制剂延缓囊肿发展并减轻肾功能下降。
  • FSK刺激肾小管上皮细胞FAK活化,该作用可被PKA抑制剂阻断。
  • 抑制FAK可中断FSK介导的Src活化及ERK和mTOR通路上调。

临床怎么用

  • FAK抑制剂可能作为ADPKD的候选治疗策略,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by numerous cysts originating from renal tubules and is associated with significant tubular epithelial cell proliferation. Focal adhesion kinase (FAK) promotes tumor growth by regulating multiple proliferative pathways. METHODS: We established the forskolin (FSK)-induced three-dimensional (3D) Madin-Darby Canine Kidney cystogenesis model and 8-bromoadenosine-3`,5`-cyclic monophosphate-stimulated cyst formation in ex vivo embryonic kidney culture. Cultured human renal cyst-lining cells (OX-161) and normal tubular epithelial cells were treated with FAK inhibitors or transfected with green fluorescent protein-tagged FAK mutant plasmids for proliferation study. Furthermore, we examined the role of FAK in two transgenic ADPKD animal models, the kidney-specific Pkd1 knockout and the collecting duct-specific Pkd1 knockout mouse models. RESULTS: FAK activity was significantly elevated in OX-161 cells and in two ADPKD mouse models. Inhibiting FAK activity reduced cell proliferation in OX-161 cells and prevented cyst growth in ex vivo and 3D cyst models. In tissue-specific Pkd1 knockout mouse models, FAK inhibitors retarded cyst development and mitigated renal function decline. Mechanically, FSK stimulated FAK activation in tubular epithelial cells, which was blocked by a protein kinase A (PKA) inhibitor. Inhibition of FAK activation by inhibitors or transfected cells with mutant FAK constructs interrupted FSK-mediated Src activation and upregulation of ERK and mTOR pathways. CONCLUSIONS: Our study demonstrates the critical involvement of FAK in renal cyst development, suggests that FAK is a potential therapeutic target in treating patients with ADPKD, and highlights the role of FAK in cAMP-PKA-regulated proliferation.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. He J, Zhang S, Qiu Z, et al. Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model. J Am Soc Nephrol. 2021. PMID: 34465607. doi:10.1681/ASN.2020111560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。